Second-trimester maternal serum analyte levels associated with fetal trisomy 13

Prenatal Diagnosis

Volumn 19, Issue 9, 1999, Pages 813-816

  Saller Jr , Devereux N ^a,g   Canick, Jacob A ^b   Blitzer, Miriam G ^c   Palomaki, Glenn E ^d   Schwartz, Stuart ^e   Blakemore, Karin J ^f   Haddow, James E ^d  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d FOUNDATION FOR BLOOD RESEARCH   (United States)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Division of Maternal Fetal Medicine   (United States)

Author keywords

AFP; Down syndrome; Maternal serum screening; Trisomy 13

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DIAGNOSTIC VALUE; DOWN SYNDROME; FEMALE; HUMAN; MATERNAL SERUM; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; STATISTICAL ANALYSIS; TRISOMY 13; TRISOMY 18;

ADOLESCENT; ADULT; ALPHA-FETOPROTEINS; CHORIONIC GONADOTROPIN; CHROMOSOMES, HUMAN, PAIR 13; ESTRIOL; FEMALE; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; TRISOMY;

EID: 0345035259     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199909)19:9<813::AID-PD639>3.0.CO;2-7     Document Type: Article

References (12)

1. Bogart MH, Pandian MR, Jones OW. 1987. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 7: 623-630.
2. Canick JA, Knight GJ, Palomaki GE, Haddow JE, Cuckle HS, Wald NJ. 1988. Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. Br J Obstet Gynaecol 95: 330-333.
3. Canick JA, Palomaki GE, Osthanondh R. 1990. Prenatal screening for trisomy 18 in the second trimester. Prenat Diagn 10: 546-548.
4. Cuckle HS, Wald NJ, Lindenbaum RH. 1984. Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome. Lancet 1: 926-929.
5. Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Canick JA, Saller DN, Bowers GB. 1992. Prenatal screening for Down syndrome with the use of maternal serum markers. N Engl J Med 327: 588-593.
6. Jones KL. 1997. Smith's Recognizable Patterns of Human Malformation, 5th edition, Philadelphia: W. B. Saunders Company; 18-19.
7. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. 1984. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 148: 886-894.
8. Palomaki GE, Haddow JE, Knight GJ, Wald NJ, Kennard A, Canick JA, Saller DN, Blitzer MG, Dickerman LH, Fisher R, Hansmann D, Hansmann M, Luthy DA, Summers AM, Wyatt P. 1995. Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin. Prenat Diagn 15: 713-723.
9. Palomaki GE, Knight GJ, Haddow JE, Canick JA, Saller DN, Panizza DS. 1992. Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin. Prenat Diagn 12: 925-930.
10. Saller DN, Canick JA, Schwartz S, Blitzer MG. 1992. Multiple marker screening in pregnancies with hydropic and non-hydropic Turner syndrome. Am J Obstet Gynecol 167: 1021-1024.
11. Suzumori K, Tanemura M, Murakami I, Okada S, Natori M, Tanaka M, Takagi T, Sato A. 1997. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy. Prenat Diagn 17: 861-866.
12. Wenstrom KD, Desai R, Owen J, Dubard MB, Boots L. 1995. Comparison of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in women ≥ 35 years old. Am J Obstet Gynecol 173: 1287-1292.